Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Did West Pharmaceutical Mislead Investors on Financial Health?
Clinical & Pharma Did West Pharmaceutical Mislead Investors on Financial Health?

In the pharmaceutical realm, maintaining integrity and transparency is crucial, especially when significant financial interests are involved. Recently, West Pharmaceutical Services, Inc., a major player in the industry, found itself under investigation following allegations of misleading investors

Can Field Medical Revolutionize VT Treatment with PFA?
Tech & Innovation Can Field Medical Revolutionize VT Treatment with PFA?

As cardiac care technologies evolve, pulsed field ablation (PFA) emerges as a promising advancement with the potential to overhaul ventricular tachycardia (VT) treatment. Field Medical, under the leadership of its inventive founder, is poised to leverage this technology not only for innovation in

Struggling Urgent Care in Sebastopol Calls for Community Support
Care Providers Struggling Urgent Care in Sebastopol Calls for Community Support

Sebastopol Urgent Care Center faces significant challenges due to diminishing local medical infrastructure, with the 2018 closure of Palm Drive Hospital in western Sonoma County leaving the area underserved for urgent care services. Residents are now reliant on facilities further afield in Santa

Navigating Compliance in Health and Finance UGC Campaigns
Management & Administration Navigating Compliance in Health and Finance UGC Campaigns

In the ever-evolving landscape of influencer marketing, the intersection of health and finance sectors presents unique compliance challenges for user-generated content (UGC) campaigns. Influencers and brands face the dual task of crafting authentic content that resonates with audiences while

How Are U.S. Cardiovascular Device Markets Evolving?
Management & Administration How Are U.S. Cardiovascular Device Markets Evolving?

The cardiovascular device market in the United States is marked by fast-paced developments, driven by significant epidemiological and technological factors that profoundly influence the healthcare industry. As cardiovascular diseases continue to be the leading health concern in the U.S., the demand

Is Public Sector Abandoning Cancer Research Funding?
Tech & Innovation Is Public Sector Abandoning Cancer Research Funding?

In an era where the fight against cancer is more critical than ever, the proposed drastic 40% cut in funding for the National Cancer Institute (NCI) by the Biden administration poses unsettling questions about the United States' commitment to combating this relentless disease. This significant

Why Digital Health Struggles to Scale And How to Change That
Editorial Why Digital Health Struggles to Scale And How to Change That

Healthcare systems worldwide are facing significant challenges. The aging population, rising chronic illnesses, workforce shortages, and increasing costs force systems to rethink how they deliver care. The potential of digital health—using technology to enhance care delivery, improve patient

Nabla Expands Healthcare AI Solutions with $70 Million Funding
Tech & Innovation Nabla Expands Healthcare AI Solutions with $70 Million Funding

Imagine a world where a healthcare professional's day is not consumed by paperwork and administrative tasks, but rather focused on patient care. With the astonishing pace at which artificial intelligence is evolving, this scenario is swiftly transitioning from a dream to reality. Today, AI is not

HIV Activists Fight Against Federal Funding Cuts in Mississippi
Clinical & Pharma HIV Activists Fight Against Federal Funding Cuts in Mississippi

The ongoing battle against HIV in the United States faces significant challenges as federal funding cuts threaten vital prevention and treatment programs. In Mississippi, where health disparities are particularly pronounced, dedicated activists like Cedric Sturdevant have risen to the occasion,

Why Do 90% of Health Startups Hit Revenue Walls?
Tech & Innovation Why Do 90% of Health Startups Hit Revenue Walls?

The health innovation sector continues to witness an influx of startups, each eager to carve a niche in an ever-evolving industry characterized by technological advancements and innovative solutions. Despite the optimism driving the establishment of new ventures, an overwhelming majority face the

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later